Quartz Partners »

Amneal Pharmaceuticals shares owned by Quartz Partners

Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by Quartz Partners from 13F filings

Historical chart of Quartz Partners investment in Amneal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amneal Pharmaceuticals held by Quartz Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amneal Pharmaceuticals by Quartz Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.6M 447k 12.43

More positions owned by Quartz Partners

Spdr Series Trust State Street Spd (SPHY)
Ishares Tr Core S&p500 Etf (IVV)
Broadcom (AVGO)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Us Aggbd Et (AGG)
Meta Platforms Cl A (META)
Restaurant Brands Intl Inc Com equity / large cap (QSR)
Amneal Pharmaceuticals Com Stk Cl A (AMRX)
Wabtec Corporation (WAB)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Novartis Sponsored Adr (NVS)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Total Stk Mkt (VTI)

View all positions for Quartz Partners

Top funds holding Amneal Pharmaceuticals

BlackRock
Vanguard Group
Tpg Gp A
Vanguard Portfolio Management
Rubric Capital Management
Vanguard Capital Management
Dimensional Fund Advisors
Morgan Stanley
Geode Capital Management
State Street Corporation
Neuberger Berman Group
Nuveen
Invesco
Assenagon Asset Management
Goldman Sachs Group

View all funds holding Amneal Pharmaceuticals